The results of polymerase chain reaction (PCR) analysis after transplantation for chronic myelogenous leukemia (CML) are difficult to interpret clinically. Positive findings for BCR/ABL can be seen not only in patients who go on to relapse but also in patients who, after years of follow-up, remain in complete remission. The cause for the lack of concordance between PCR findings and relapse is not clear. We identified two patients with CML who had rare pseudo-Gaucher cells in their bone marrow aspirate specimens prior to, and at 1, and 6 or 12 months following syngeneic or allogeneic hematopoietic transplantation. After the transplant, the patients obtained clinical remission and were shown to be cytogenetically normal and to have germline MBCR in blood or bone marrow by Southern analysis. One patient was PCR-positive for BCR/ABL in the marrow at 12 months. In order to determine whether the pseudo-Gaucher histiocytes were BCR/ABL-positive, we used fluorescence in situ hybridization and probes for MBCR and ABL and analyzed Wright-stained smears to correlate molecular cytogenetic findings with cell type. On three aspirate smears from each patient (at 6 or 12 months post-transplant), all of the pseudo-Gaucher cells studied (10/10 in one patient and 12/12 in the other) showed the fusion for BCR/ABL. Other cells analyzed randomly (erythroid precursors, granulocytes and rare monocytes, lymphocytes and plasma cells) did not. Our cases provide the first proof that pseudo-Gaucher cells carry the BCR/ABL fusion. Furthermore, they illustrate that these cells can be found in the marrow for up to 12 months following transplantation. Our results permit speculation that pseudo-Gaucher cells or other long-lived histocytes may be one cause of persistent PCR positivity after transplantation that is not predictive of disease relapse.
Introduction
Pseudo-Gaucher cells are seen in the bone marrow specimens of 20 to 40% of patients with chronic myelogenous leukemia (CML) and are histiocytes with plump, blue, lamellar cytoplasm that resemble the glucocerebroside-stuffed histiocytes seen in Gaucher disease. [1] [2] [3] In CML, pseudo-Gaucher cells are believed to arise from increased hemophagocytic activity associated with the high turnover of hematopoietic elements. 4 Because the pseudo-Gaucher cells in CML are monocyte/macrophage-derived, they are assumed to arise from the CML clone and carry the Philadelphia (Ph) chromosome, although this has not been established directly.
In CML, the Ph chromosome results from the fusion of BCR and ABL genes (BCR/ABL). This molecular lesion can be amplified by the polymerase chain reaction (PCR), making it Correspondence: J Anastasi, University of Chicago Medical Center, MC0008, 5841 South Maryland Avenue, Chicago, IL 60637, USA; Fax: 773-702-1200 Received 29 July 1997; accepted 10 October 1997 possible to identify as few as one abnormal CML cell in as many as 10 5 or 10 6 non-rearranged cells. Although PCR would seem to be a useful tool for the detection of minimal residual disease in CML, positive findings from patients treated with bone marrow transplantation (BMT) have been difficult to interpret. PCR positivity in the absence of clinical, morphologic and cytogenetic evidence for disease has been reported not only in patients who eventually relapse, but also in an almost equal fraction of patients who, after as many as 10 years of follow-up, have not developed recurrent disease. [5] [6] [7] [8] [9] [10] [11] [12] In addition, reports have differed regarding the incidence of positive findings, and the importance of optimal time interval after transplantation for the evaluation. Thus, there has been no consensus regarding how positive PCR results should be interpreted and used clinically.
Why positive PCR findings do not show a more direct correlation with disease relapse is not well understood. However, it has been reasoned that positive PCR results after BMT can arise not only from residual leukemia cells that may eventually lead to a relapse, but also from residual leukemia cells which might later be suppressed by a graft-versus-leukemia effect. [5] [6] [7] It has also been suggested that positive PCR findings might be due to BCR/ABL + cells that are non-clonogenic, but that linger in the bone marrow after transplantation. 5, 7, 8, 10 Some authors have wondered whether these latter cells might be long-lived B or T cells or stromal histiocytes/macrophages, but this has never been proved.
We identified rare pseudo-Gaucher histiocytes in the bone marrow specimens of two CML patients who were in complete remission after a syngeneic BMT or allogeneic stem cell transplant, and we undertook fluorescence in situ hybridization (FISH) analysis to determine whether these cells were BCR/ABL + . We have previously demonstrated that FISH can be performed on Wright-stained slides for correlation of molecular cytogenetic findings with cytomorphology. 13, 14 Our findings not only indicate that the pseudo-Gaucher cells carry the BCR/ABL fusion and are part of the CML clone, but they illustrate that such cells can be identified in the bone marrow up to 1 year following bone marrow transplantation. The findings in these cases permit speculation that long-lived clonal histiocytes may be one cause of persistent PCR positivity after successful transplantation in CML. They also may have implications regarding the interpretation of molecular studies for the detection of minimal residual disease in patients with other malignancies in which the neoplastic clone may differentiate into cells of the monocyte/histiocyte series.
Case reports
Patient 1 was a 19-year-old woman who presented with a white blood cell (WBC) count of 454 000/l in July 1995. She was diagnosed with CML (Ph-negative), which was shown to have a rearrangement of the major breakpoint of BCR (MBCR) by Southern analysis (see Table 1 ). The patient was treated with hydroxyurea, and a follow-up bone marrow examination during treatment (December 1995) showed changes consistent with CML with therapy effect. At this time, pseudoGaucher cells were noted to be present. Cytogenetic analysis of this follow-up specimen showed an abnormal female karyotype, 46,XX,t(6;18)(p23;q21.1)[36%]/46,XX[64%] in 22 metaphase cells. Although chromosome 22 appeared normal, a fusion for BCR/ABL was found on the long arm of this chromosome by FISH analysis (10/10 cells positive). In January 1996 the patient received a syngeneic BMT after a preparative regimen of busulfan (16 mg/kg over 4 days) and cyclophosphamide (60 mg/kg on each of 2 days). A bone marrow examination at day 30 showed a normocellular marrow with some pseudo-Gaucher cells. Cytogenetic study of this specimen showed a normal female karyotype. A repeat bone marrow study at 1 year showed no morphologic evidence of residual CML, but rare pseudo-Gaucher cells were still seen ( Figure  1a , and insert). Southern analysis of bone marrow cells for BCR rearrangement with a probe which had demonstrated the translocation prior to transplant showed only germline DNA (Figure 1b ), whereas PCR of the same specimen gave positive findings (Figure 1c) .
Patient 2 was a 28-year-old man with chronic phase CML diagnosed in October 1995, when he had a WBC count of 339 000/l. At presentation, the karyotype was not studied; however, the diagnosis was confirmed in May 1996, when cytogenetic study revealed 46,XY,t(9;22)(q34;q11.2) in each of 21 metaphase cells, and molecular study showed rearrangement of MBCR by Southern analysis (see Table 1 ). The bone marrow examination at this time revealed chronic phase CML with rare pseudo-Gaucher cells. In June 1996, the patient received an allogeneic blood stem cell transplant after a preparative regimen of busulfan and cyclophosphamide (as above). The donor was the patient's brother, who was HLAidentical and non-reactive in the mixed lymphocyte culture reaction. Thirty days after the transplant, a bone marrow examination showed a regenerating normocellular bone marrow. Rare pseudo-Gaucher cells were identified. Six months after the transplant, a bone marrow examination showed no residual CML, but there was erythroid hyperplasia, apparently due to a chronic hemolytic anemia of undetermined cause. Rare pseudo-Gaucher cells were again noted. Cytogenetic analysis of the 6 month post-transplant specimen revealed a 
Materials and methods
FISH studies were performed with probes for the BCR and ABL genes (Oncor, Gaithersburg, MD, USA) capable of demonstrating the BCR/ABL fusion involving the major breakpoint of BCR, as usually seen in CML. Studies correlating FISH results with morphology were undertaken by methods previously published. 13, 14 Briefly, freshly made bone marrow aspirate smears were stained with Wright's stain and mounted with Pro Texx (Baxter Diagnostics, Deerfield, IL, USA) mounting medium. Images of the Wright-stained cells were videotaped while the location of the cells indicated by the microscope grid was noted. The coverslips were removed, and the slides were soaked in xylene for 5 min, air-dried and then hybridized with the BCR/ABL probes according to the standard hybridization procedure. 13 When the FISH analysis was complete, we correlated them with the morphology by returning to the stored images of the Wright-stained cells and by relocating the cells to evaluate the FISH results. The cells were scored as showing either the normal pattern of two red (BCR) and two green (ABL) signals, or a pattern of one red, one green, and a yellow fusion signal indicating the presence of the BCR/ABL fusion.
Results
Rare pseudo-Gaucher histiocytes were identified in the bone marrow specimens of both patients obtained 12 or 6 months after transplantation (patients 1 and 2, respectively). These cells accounted for approximately 1. case the remaining pseudo-Gaucher cells could not be evaluated because of intense cytoplasmic autofluorescence obscuring the nucleus, loss of cells during the hybridization or incomplete hybridization). Other cells randomly analyzed (erythroid precursors, neutrophils, and rare monocytes, and lymphocytes/plasma cells showed two red and two green signals (Figure 2 ), except for rare cells with juxtaposed signals (three cells of 183 total cells studied in patient 1, and one of 180 cells in patient 2), which is within the range of false positive cells (Ͻ2-3%) usually expected for this probe set.
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Discussion
In this report, we have demonstrated that in CML, pseudoGaucher histiocytes carry the Philadelphia chromosome, and can be identified in the bone marrow at least 12 months after transplantation. We speculate that these cells may be one cause of persistent PCR positivity that is not predictive of relapsing disease.
To our knowledge, this is the first direct evidence that pseudo-Gaucher cells in CML are BCR/ABL + . Although the cells were rare and would have been far below the false positivity rate of FISH analysis if evaluated within the entire cellular population, our ability to specifically focus analysis on this morphologically distinct population, and the results that virtually all pseudo-Gaucher cells showed the fusion, excludes concern regarding specificity of the analysis. The finding that pseudo-Gaucher cells are BCR/ABL-positive is not surprising, given the fact that CML is a stem cell disorder and that the clonal hematopoietic stem cell is capable of giving rise to cells of all lineages. In fact, previous work has illustrated the Ph chromosome in the monocyte/macrophage/histiocyte lineage, 17 and specifically in pulmonary alveolar macrophages. 18 Pseudo-Gaucher cells can be seen in any phase of CML. In the patients presented here, they were recognized in the chronic phase prior to transplantation and were morphologically identified in low numbers at 1, 6 and 12 months after transplantation. FISH studies demonstrating the fusion signal were done only at 6 or 12 months and were not successful when performed retrospectively on stored smears obtained earlier. The absence of fusion signals in other cell types after transplantation suggested to us that these histiocytic cells or their immediate committed precursors persisted from before the transplant rather than evolving from a BCR/ABL + multipotent progenitor after it. Although this persistence cannot be determined with certainty, there was no indication of increased cellular turnover that may have stimulated in pseudo-Gaucher cell formation, at least in patient 1. If the pseudo-Gaucher did persist from before the transplant they may have done so by escaping the cytotoxic effect of the transplant regimen due to their low turnover rate. The finding of rare BCR/ABL + histiocytic elements in our two patients may add another variable which could complicate the interpretation of PCR analysis for evaluating residual disease in CML. Although we cannot prove that the BCR/ABL mRNA was from the histiocytes, and although we do not yet have a long-term follow-up on our two patients (patients 1 and 2 remain in remission at 22 and 16 months, respectively), our findings illustrate that long-lived, non-clonogenic cells may potentially be a cause of persistent PCR positivity up to 1 year following transplantation. Our findings might explain why a single positive PCR analysis or even persistent positivity in the marrow on several tests might not predict relapse. This may also be the case with blood specimens, because tissuederived histiocytes are known to circulate. 19, 20 We would suspect that, with increasing time after transplantation, positivity due to these terminally differentiated cells would diminish, although it is not clear how long these histiocytes can persist. Our findings also add support to the conclusion of Lion et al 21 and Lin et al 22 that quantitative PCR and the finding of increasing clone size are probably a more logical predictor of relapsing disease than is a qualitative study alone.
Our demonstration of histiocytes with BCR/ABL fusions in CML in remission also may have relevance to the interpretation of positive PCR results in remission specimens of other leukemic disorders in which the leukemic clone is capable of monocyte/macrophage differentiation. We conclude that the significance of a positive PCR result in a remission sample may be interpreted better if one can identify the cell type in which the abnormality is present.
